Clinical Trial

Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk

Name: Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk — clinical trial record (NCT07374978)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

The aim of investigators was to study the effect and safety of Thrombolysis in Intermediate high risk pulmonary embolism patients with low bleeding risk as regards Mortality and bleeding events.

Trial Details

NCT Number	NCT07374978
Lead Sponsor	Ain Shams University
Conditions	Pulmonary Embolism Subacute Massive, Thrombolytic Therapy
Enrollment	100 participants
Start Date	2023-07-01
Primary Completion	2025-05-01 (estimated)
Study Completion	2025-07-01 (estimated)
Updated on ClinicalTrials.gov	2026-01-29